Stock XSNX NOVACCESS GLOBAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News NovAccess Global Inc.

Equities

XSNX

US67001N1072

Market Closed - OTC Markets
Other stock markets
 19:14:33 25/06/2024 BST 		5-day change 1st Jan Change
0.008 USD -32.20% Intraday chart for NovAccess Global Inc. -33.33% -60.20%
05-31 NovAccess Global Inc. announced that it has received $0.009 million in funding CI
05-21 NovAccess Global Inc. Files Patent with Cedars-Sinai to Advance Its Brain Cancer Fighting Vaccine Platform CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NovAccess Global : Material Agreement Form 8 K
PU
NovAccess Global Inc. announced that it has received $0.009 million in funding
CI
NovAccess Global Inc. Files Patent with Cedars-Sinai to Advance Its Brain Cancer Fighting Vaccine Platform
CI
NovAccess Global Inc. acquired 18.60% stake in Fendix Media Ltd from David Sumner for $0.12 million.
CI
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
NovAccess Global Inc. announced that it has received $0.1053 million in funding from AJB Capital Investments LLC
CI
NovAccess Global : Announces New License to Advance its Immunotherapy Platform
PU
NovAccess Global Inc. announced that it has received $0.0265 million in funding from AJB Capital Investments LLC
CI
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
NovAccess Global Inc. announced that it has received $0.1 million in funding from AJB Capital Investments LLC
CI
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
CI
NovAccess Global Announces $10.7 Million Financing
AQ
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
NE
NovAccess Global Inc. Appoints Roscoe M. Moore, Jr. to Scientific Advisory Board
CI
NovAccess Global Inc. announced that it expects to receive $10.68 million in funding from Sumner Capital Pty Ltd.
CI
NovAccess Global Inc. announced that it expects to receive $0.055 million in funding
CI
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
CI
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
AQ
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform
CI
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XSNX Stock
  4. News NovAccess Global Inc.